Opportunities and Challenges in Democratizing Immunology Datasets. Read more about Opportunities and Challenges in Democratizing Immunology Datasets.
Adapting T Cell Receptor Ligand Discrimination Capability via LAT. Read more about Adapting T Cell Receptor Ligand Discrimination Capability via LAT.
VectorMOD: Method for Bottom-Up Proteomic Characterization of rAAV Capsid Post-Translational Modifications and Vector Impurities. Read more about VectorMOD: Method for Bottom-Up Proteomic Characterization of rAAV Capsid Post-Translational Modifications and Vector Impurities.
The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28. Read more about The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28.
Phenotypic and Functional Analyses Guiding Combination Immune Checkpoint Immunotherapeutic Strategies in HTLV-1 Infection. Read more about Phenotypic and Functional Analyses Guiding Combination Immune Checkpoint Immunotherapeutic Strategies in HTLV-1 Infection.
Use of Post-transplant Cyclophosphamide Treatment to Build a Tolerance Platform to Prevent Liquid and Solid Organ Allograft Rejection. Read more about Use of Post-transplant Cyclophosphamide Treatment to Build a Tolerance Platform to Prevent Liquid and Solid Organ Allograft Rejection.
Use of the Tissue Common Rejection Module Score in Kidney Transplant as an Objective Measure of Allograft Inflammation. Read more about Use of the Tissue Common Rejection Module Score in Kidney Transplant as an Objective Measure of Allograft Inflammation.
Schistosomiasis Pulmonary Arterial Hypertension. Read more about Schistosomiasis Pulmonary Arterial Hypertension.
Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response. Read more about Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response.
Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity. Read more about Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity.
